Normal bone marrow cells, however, are spared, which may explain why bean extracts kill off colon cancer cells, but seem to leave normal colon cells alone.
To confirm the finding,
normal bone marrow cells were exposed to either IMGN632 or X-ADC for 72 hours at a concentration highly active against AML cells (100 pM), and the degree of caspase 3 activation, a marker of apoptosis, in different cell populations was assessed by flow cytometry (supplemental Figure 4).
Importantly, IMGN632 was effective at concentrations well below those that affected
normal bone marrow cells, suggesting the potential for efficacy in AML patients with reduced likelihood of myelosuppressive side effects and favorable safety profile.
Myelosuppression is a well - established side effect of current AML therapies, with prolonged events leading to an increased risk of infections and death.44 Consequently, therapies that preferentially kill leukemic cells over
normal bone marrow cells are urgently required, and the overexpression of CD123 on AML leukemic stem cells and blasts compared with normal hematopoietic cells contributes to its attractiveness as a therapeutic target in this disease.6, 45 However, severe myelosuppression and myeloablation have emerged for some investigational CD123 - targeted treatment modalities.
Patients were considered free of MRD if less than one cancer cell could be detected in 1,000
normal bone marrow cells.
Not exact matches
Multiple myeloma causes tumors to grow in the
bone marrow, preventing the production of
normal blood
cells.
In humans, a comparison of
bone marrow from 14
normal bone marrow donors, 35 multiple myeloma patients and 11 patients with a noncancerous condition called monoclonal gammopathy of undetermined significance (MGUS) showed that Runx2 levels were significantly higher in the multiple myeloma
cells.
In DBA, a mutation prevents a patient's
bone marrow from producing
normal quantities of red blood
cells, resulting in severe, sometimes life - threatening anemia.
Subsequent transplant of millions of human T - ALL
cells into
normal mice that were then treated with an anti-CXCR4 drug induced remission within two weeks, with diseased spleen and
bone marrow tissue nearly returning to
normal.
Then they would transfuse donor
bone marrow rich in the highly prized stem
cells that are capable of generating new,
normal blood.
Everybody has suPAR, which is produced by
bone marrow cells, in their blood, with
normal levels around 2400 picogram per milliliter (pg / ml).
Bone marrow from the p16 - deficient mice made 3 times as many blood - forming stem cells as bone marrow from the normal mice
Bone marrow from the p16 - deficient mice made 3 times as many blood - forming stem
cells as
bone marrow from the normal mice
bone marrow from the
normal mice did.
«Chemotherapy is applied in one cycle then stopped to allow your
bone marrow and
normal stem
cells to recover from the damage, and then another cycle starts again,» he said.
For every 100 DNA fragments, only one may come from the tumor, and the rest may come from
normal cells, mainly
bone marrow cells,» said Dr. Razavi.
People in an acute stage of the disease often develop severe anemia, because the leukemia
cells, which live almost ten times as long as their
normal counterparts, replace healthy
cells in the
bone marrow.
They multiply quickly and interfere with the
bone marrow's ability to make
normal blood
cells, leading to life - threatening infections and bleeding.
Researchers at the Whitehead Institute in Cambridge, Massachusetts, US, have now found that adult stem
cells in
bone marrow gradually lose their ability to regenerate without their
normal complement of membrane - bound prions.
To devise a potential new therapy, the investigators engineered a population of
bone marrow derived mesenchymal stem
cells loaded with oncolytic herpes simplex virus (oHSV), which specifically kills dividing cancer
cells while sparing
normal cells.
When blasted with 10 Gy of irradiation — enough to wipe out all blood stem
cells in the
bone marrow of
normal mice — mutant mice that were unable to fully activate p53 experienced only a modest blood count drop.
(5 - azacytidine, Vidaza) A demethylating agent, this medicine interacts with DNA to restore
normal growth of blood
cells in the
bone marrow.
(Dacogen) A demethylating agent, this drug interacts with DNA to restore
normal growth of blood
cells in the
bone marrow.
In a third of MDS cases, over time, very immature
bone marrow cells called blasts may increase in number and fill the
bone marrow, displacing the
normal red and white blood
cells and platelets that are produced there.
CFU - GM assays using
bone marrow derived
cells yield very few colonies in repsonse to interleukin 3, but
normal colony growth occurs in response to GM - CSF
She will study how
normal, healthy
bone marrow stem
cells find a niche and how niche environment regulates stem
cell functions such as self - renewal and differentiation.
Her goal is to define the molecular architecture and functional significance of a niche, determine how tumor growth impacts the niche, learn how benign and malignant
cells compete within a niche, and use this knowledge to design precisely targeted anti-cancer treatments that spare
normal bone marrow and improve the efficacy of stem
cell - based therapies.
Stem
Cells Make Bone Marrow Cancer Resistant to Treatment Scientists at the Johns Hopkins Kimmel Cancer Center provided evidence that cancer stem cells for multiple myeloma share many properties with normal stem cells and have multiple ways of resisting chemotherapy and other treatm
Cells Make
Bone Marrow Cancer Resistant to Treatment Scientists at the Johns Hopkins Kimmel Cancer Center provided evidence that cancer stem
cells for multiple myeloma share many properties with normal stem cells and have multiple ways of resisting chemotherapy and other treatm
cells for multiple myeloma share many properties with
normal stem
cells and have multiple ways of resisting chemotherapy and other treatm
cells and have multiple ways of resisting chemotherapy and other treatments.
In her project, Sipkins will investigate molecular characteristics of tissue microenvironments, or «niches,» within the
bone marrow and how
normal, healthy hematopoietic stem
cells, which give rise to the many kinds of blood
cells, compete with malignant
cells to occupy these coveted niches.
If successful, the
bone marrow will then produce all new blood
cells, including
normal hemoglobin.
the removal and evaluation of
bone marrow cells to determine if the
cells are
normal, if cancer has spread to the
bone marrow or if there is a problem with blood
cell production.
The signs that we see in dogs are usually related to decreased numbers of
normal cells (such as red blood
cells which carry oxygen, white blood
cells that fight infection and platelets that help with clotting) which are made in the
bone marrow.
Unfortunately,
normal healthy
cells can also be damaged or destroyed by the radiation, particularly actively dividing
cells like those of the intestinal lining,
bone marrow and immune system.
This means that abnormal blood
cells can be produced or that production of
normal cells can be halted due to an action of chloramphenicol on patient
bone marrow.
Immunoglobulin levels can also remain above
normal in all forms of autoimmune disease (ref + see ANA) and when tumors have developed in certain
bone marrow cells.